GO:0003684 damaged DNA binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0003684 (damaged DNA binding) is a molecular function defined as binding to damaged DNA, enabling proteins to recognize and initiate repair of DNA lesions [1,3].
• Key proteins include XPA, RPA, DDB1, DDB2, and AGT, which detect UV-induced photoproducts, bulky adducts, and alkylation damage [1,3,5,8].
• Damaged DNA binding is the first step in nucleotide excision repair (NER) and base excision repair (BER), and defects cause xeroderma pigmentosum and cancer predisposition [1,3].
• Experimental methods such as EMSA, fluorescence anisotropy, and next-generation DNA damage sequencing are used to study damaged DNA binding [4,6,8].
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal dissection of genes involved in damaged DNA binding [3,5].
• EDITGENE provides custom cell models and CRISPR library screening to accelerate research on damaged DNA binding and DNA repair.
Description
Damaged DNA binding (GO:0003684) is a molecular function that enables proteins to specifically recognize and bind to DNA lesions, such as UV-induced photoproducts, chemical adducts, and alkylation damage [1,3]. This function is essential for the initial step of DNA repair pathways, including nucleotide excision repair (NER) and base excision repair (BER), and is critical for maintaining genomic integrity [3,5]. The QuickGO definition states that this term encompasses binding to damaged DNA, and it is synonymous with DNA repair enzyme or DNA repair protein. Researchers study damaged DNA binding to understand how cells detect and respond to DNA damage, and how defects in this process lead to diseases such as xeroderma pigmentosum and cancer [1,3]. The proteins involved, such as XPA, RPA, DDB1, and DDB2, have been extensively characterized using biochemical and structural approaches [5,8]. Recent advances in next-generation DNA damage sequencing have further illuminated the genomic distribution and repair kinetics of damaged DNA binding events. This article provides a comprehensive overview of the mechanisms, key genes, research methods, and disease relevance of GO:0003684, with a focus on publication-ready insights for biomedical researchers.
damaged DNA binding At A Glance
| GO ID | GO:0003684 |
|---|---|
| GO term | damaged DNA binding |
| Ontology | molecular_function |
| Synonym | DNA repair enzyme, DNA repair protein |
| Major function | Binding to damaged DNA, initiating DNA repair pathways such as NER and BER |
| Definition | Binding to damaged DNA. |
| Related pathways | Nucleotide excision repair, base excision repair, DNA damage response |
| Key proteins | XPA, RPA, DDB1, DDB2, AGT, UV-DDB |
What Is GO:0003684?
Damaged DNA binding (GO:0003684) is defined as the molecular function of binding to damaged DNA. This includes the ability of proteins to recognize and physically interact with DNA lesions such as UV-induced cyclobutane pyrimidine dimers, 6-4 photoproducts, cisplatin adducts, and alkylated bases [1,3]. The term is synonymous with DNA repair enzyme and DNA repair protein, reflecting the role of these proteins in the initial steps of DNA repair pathways. This function is distinct from general DNA binding because it requires specificity for damaged bases or distorted DNA structures, often mediated by specialized domains such as the UV-damaged DNA-binding domain (UV-DDB) or the xeroderma pigmentosum group A (XPA) domain [1,5].
Why Is damaged DNA binding Important in Cell Biology?
Damaged DNA binding is a fundamental molecular function that underpins the first step of DNA repair, ensuring genomic stability and preventing mutations that can lead to cancer and premature aging [3,5]. Defects in this function are directly linked to human diseases such as xeroderma pigmentosum, Cockayne syndrome, and various cancers [1,3]. Understanding damaged DNA binding is also critical for developing therapeutic strategies that target DNA repair pathways, such as PARP inhibitors and platinum-based chemotherapies. Moreover, the ability to measure and manipulate damaged DNA binding in model systems is essential for basic research and drug discovery [6,8].
• Initiates nucleotide excision repair (NER) by recruiting repair factors to UV-induced lesions [1,3].
• Enables base excision repair (BER) through damage-specific DNA glycosylases and AGT.
• Prevents mutations and cancer by maintaining genomic integrity [3,5].
• Defects cause xeroderma pigmentosum, a photosensitive cancer-prone disorder.
• Plays a role in chromatin remodeling during DNA repair.
• Serves as a target for cancer therapeutics that exploit DNA repair deficiencies.
• Facilitates DNA damage detection in aging and neurodegeneration.
• Provides a basis for developing CRISPR models to study DNA repair gene function [3,5].
• Enables high-throughput screening for DNA damage response modulators.
• Supports personalized medicine by predicting responses to DNA-damaging agents.
Molecular Mechanism of damaged DNA binding
Recognition of DNA lesions
In simple terms: Proteins scan DNA and recognize abnormal structures caused by damage.
Damaged DNA binding proteins such as XPA and DDB2 recognize helical distortions and specific photoproducts. XPA binds to damaged DNA with high affinity, as shown by fluorescence anisotropy studies. DDB2, part of the UV-DDB complex, specifically binds to UV-induced 6-4 photoproducts and cyclobutane pyrimidine dimers [1,3]. The binding is often accompanied by base flipping, as observed for AGT with methyl-damaged DNA.
Dimerization and conformational changes
In simple terms: Some proteins pair up and change shape to grip damaged DNA more tightly.
UV-DDB undergoes dimerization upon binding to damaged DNA, which enhances its affinity and facilitates chromatinized DNA repair. This dimerization is essential for recruiting downstream repair factors and for efficient NER. Similarly, RPA binds to single-stranded DNA generated during repair and interacts with XPA to stabilize the repair complex.
Coordination with repair machinery
In simple terms: The damage-binding proteins call in other repair tools to fix the DNA.
After initial damage recognition, XPA and RPA recruit TFIIH, XPC, and other NER factors to the lesion site [1,3]. DDB2 also promotes the recruitment of XPC and facilitates chromatin remodeling [3,5]. In BER, AGT directly reverses alkylation damage by transferring the alkyl group to itself, a process that involves base flipping and specific binding to methyl-damaged DNA.
Regulation by post-translational modifications
In simple terms: Chemical tags on repair proteins control when and where they bind damaged DNA.
Phosphorylation, ubiquitination, and SUMOylation regulate the activity and localization of damaged DNA binding proteins. For example, DDB2 is ubiquitinated after UV irradiation, which modulates its binding to damaged DNA and its degradation. XPA activity is also regulated by phosphorylation and acetylation, affecting its interaction with damaged DNA.
Kinetics and affinity of binding
In simple terms: How strongly and how long a protein sticks to damaged DNA determines repair efficiency.
Binding affinity and kinetics are measured using techniques such as fluorescence anisotropy and electrophoretic mobility shift assays (EMSA) [6,8]. XPA binds to damaged DNA with nanomolar affinity, while RPA binds with lower affinity but higher abundance. The binding strength of AGT to methyl-damaged DNA is influenced by the extent of base flipping and the nature of the alkyl adduct.
Key Genes Involved in GO:0003684 damaged DNA binding
The following genes encode proteins that directly bind damaged DNA or are essential for this molecular function.
| Gene | Major Role | Research Relevance |
|---|---|---|
| XPA | Binds to damaged DNA and recruits NER factors | Defects cause xeroderma pigmentosum; target for NER studies [1,8] |
| RPA1 | Binds single-stranded DNA during repair | Essential for NER and DNA replication; interacts with XPA |
| DDB1 | Component of UV-DDB complex; binds damaged DNA | Mutations linked to xeroderma pigmentosum group E [1,3] |
| DDB2 | Binds UV-induced photoproducts; initiates NER | Defects cause xeroderma pigmentosum group E; regulates chromatin [3,5] |
| AGT | Directly reverses alkylation damage by base flipping | Studied for alkylation repair and drug resistance |
| XPC | Binds damaged DNA and recruits TFIIH | Mutations cause xeroderma pigmentosum group C |
| ERCC1 | Forms complex with XPF; binds damaged DNA | Defects cause xeroderma pigmentosum and Cockayne syndrome |
| XPF | Structure-specific endonuclease; binds damaged DNA | Mutations cause xeroderma pigmentosum group F |
| TFIIH | Helicase and kinase complex; binds damaged DNA | Defects cause xeroderma pigmentosum and trichothiodystrophy |
| PARP1 | Binds DNA strand breaks; poly(ADP-ribosyl)ation | Target for cancer therapy; involved in BER |
| OGG1 | Binds and excises oxidized guanine | Defects linked to cancer and neurodegeneration |
| MUTYH | Binds oxidized adenine; BER glycosylase | Mutations cause MUTYH-associated polyposis |
| NEIL1 | Binds oxidized pyrimidines; BER glycosylase | Involved in oxidative DNA damage repair |
| APEX1 | Binds abasic sites; AP endonuclease | Essential for BER; target for inhibitor development |
| LIG3 | Binds nicked DNA; ligates during BER | Required for BER and mitochondrial DNA repair |
| XRCC1 | Scaffold protein; binds damaged DNA | Defects cause sensitivity to DNA-damaging agents |
| SMUG1 | Binds and excises uracil; BER glycosylase | Involved in base excision repair |
| TDG | Binds and excises mismatched bases | Regulates epigenetic marks and BER |
How Is damaged DNA binding Regulated?
Damaged DNA binding is regulated at multiple levels, including post-translational modifications, protein-protein interactions, and chromatin context. Phosphorylation of XPA by ATR and ATM modulates its binding to damaged DNA and its recruitment to repair foci. Ubiquitination of DDB2 by the CRL4-DDB1 E3 ligase complex regulates its stability and activity after UV irradiation. SUMOylation of XPC enhances its binding to damaged DNA and promotes NER. Additionally, chromatin remodeling factors such as the SWI/SNF complex facilitate access of damaged DNA binding proteins to lesions within nucleosomes. The availability of ATP and the presence of damage sensors like PARP1 also influence the kinetics of damaged DNA binding.
damaged DNA binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| XPA | Xeroderma pigmentosum, neurological abnormalities | Knockout mice, patient-derived fibroblasts |
| DDB2 | Xeroderma pigmentosum group E, cancer | DDB2 knockout cell lines, UV sensitivity assays |
| XPC | Xeroderma pigmentosum group C, skin cancer | XPC knockout mice, NER assays |
| AGT | Alkylation damage, drug resistance | AGT overexpression in cancer cells, MGMT inhibitor studies |
| OGG1 | Oxidative DNA damage, neurodegeneration | OGG1 knockout mice, oxidative stress models |
Xeroderma pigmentosum and related disorders
Mutations in genes encoding damaged DNA binding proteins, such as XPA, XPC, DDB2, and ERCC1, cause xeroderma pigmentosum (XP), a rare autosomal recessive disorder characterized by extreme sensitivity to UV light and a high risk of skin cancer [1,3]. DDB2 mutations are specifically associated with XP complementation group E [1,3]. These patients exhibit defective NER and accumulate UV-induced DNA damage, leading to freckling, actinic keratoses, and skin cancers.
Cancer predisposition and therapy resistance
Defects in damaged DNA binding can lead to genomic instability and cancer predisposition. For example, reduced expression of DDB2 is observed in various cancers and is associated with poor prognosis. Conversely, overexpression of damaged DNA binding proteins like XPA can confer resistance to platinum-based chemotherapies by enhancing NER. Targeting these proteins with inhibitors is a promising strategy to sensitize tumors to DNA-damaging agents.
Neurodegeneration and aging
Impaired damaged DNA binding and repair contribute to neurodegeneration. Mutations in XPA and XPC can cause neurological abnormalities in XP patients. Additionally, oxidative DNA damage binding proteins such as OGG1 and MUTYH are implicated in age-related neurodegenerative diseases like Alzheimer's and Parkinson's. Defective BER due to impaired damaged DNA binding leads to accumulation of oxidative lesions in neurons, promoting cell death.
From damaged DNA binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does XPA loss impair NER? | XPA knockout cell line (e.g., HeLa or HAP1) |
| Does a point mutation in DDB2 affect UV-DDB dimerization? | DDB2 point-mutation knock-in cell line |
| Can overexpression of AGT protect against alkylating agents? | AGT overexpression cell line |
| How does tagging XPC affect its recruitment to damage sites? | XPC knock-in with fluorescent tag (e.g., GFP) |
| What is the genome-wide binding profile of RPA after UV? | RPA ChIP-seq in wild-type and knockout cells |
| Does CRISPR knockout of OGG1 increase oxidative DNA damage? | OGG1 knockout cell line, comet assay |
How to Study the damaged DNA binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| EMSA | Protein-DNA complex formation | Binding affinity and specificity of XPA, RPA, DDB2 |
| Fluorescence anisotropy | Binding affinity and kinetics | Quantitative interaction of XPA and RPA with damaged DNA |
| Damage-seq | Genome-wide DNA damage distribution | Mapping UV-induced lesions and repair kinetics |
| XR-seq | Excision repair sites | Measuring NER activity across the genome |
| ChIP-seq | Protein binding sites on DNA | Genome-wide localization of XPC, DDB2, RPA [4,5] |
| Comet assay | DNA strand breaks | Assessing oxidative DNA damage in knockout cells |
| Surface plasmon resonance | Real-time binding kinetics | Measuring affinity of AGT to methylated DNA |
| Isothermal titration calorimetry | Thermodynamics of binding | Characterizing DDB2-damaged DNA interactions |
Electrophoretic mobility shift assay (EMSA)
EMSA is a classic method to study protein binding to damaged DNA. It measures the formation of protein-DNA complexes by their reduced mobility in a gel. This technique is used to assess the binding affinity and specificity of proteins such as XPA, RPA, and DDB2 to defined DNA lesions [6,8].
Fluorescence anisotropy
Fluorescence anisotropy provides quantitative measurements of binding affinity and kinetics in solution. It has been used to study the interaction of XPA and RPA with damaged DNA, revealing nanomolar affinities and cooperative binding. This method is sensitive and suitable for high-throughput screening.
Next-generation DNA damage sequencing
Next-generation sequencing-based methods, such as Damage-seq and XR-seq, map DNA damage and repair at single-nucleotide resolution across the genome. These techniques have been used to study the genomic distribution of UV-induced lesions and the binding of repair proteins like DDB2 and XPC.
Chromatin immunoprecipitation (ChIP)
ChIP combined with sequencing (ChIP-seq) allows genome-wide mapping of damaged DNA binding proteins. It has been used to determine the binding sites of XPC, DDB2, and RPA after DNA damage [4,5]. This method reveals how chromatin context influences damaged DNA binding.
How CRISPR Can Be Used to Study GO:0003684 damaged DNA binding
Knockout
CRISPR knockout of genes encoding damaged DNA binding proteins, such as XPA, DDB2, or OGG1, allows researchers to assess their essential roles in DNA repair. For example, DDB2 knockout cells show reduced NER efficiency and increased UV sensitivity. Knockout models are also used to validate drug targets and to study synthetic lethality with other repair pathways.
Point Mutation
Point mutations can be introduced to mimic patient-derived missense mutations or to dissect functional domains. For instance, point mutations in the DDB2 gene can disrupt its binding to damaged DNA or its interaction with DDB1, providing insights into XP-E pathogenesis [1,3]. CRISPR point mutation models are valuable for studying structure-function relationships.
Knock-in
Knock-in of tagged versions of damaged DNA binding proteins, such as GFP-XPC or FLAG-XPA, enables live-cell imaging and biochemical purification. These models help track the recruitment of repair proteins to damage sites in real time [1,5]. Knock-in of patient-specific mutations can also create isogenic disease models.
Overexpression
Overexpression of damaged DNA binding proteins, such as AGT or XPA, is used to study their effects on DNA repair capacity and drug resistance. For example, AGT overexpression protects cells from alkylating agents like temozolomide. Overexpression models are also useful for producing recombinant proteins for structural studies.
How EDITGENE Supports damaged DNA binding Research
Researchers studying damaged DNA binding-related genes often need to determine whether a candidate gene is causally involved in DNA repair, whether a specific mutation alters binding affinity, or whether overexpression confers a selective advantage. EDITGENE provides a comprehensive suite of CRISPR-based cell models and screening services to address these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for damaged DNA binding research.
Frequently Asked Questions About damaged DNA binding
What is damaged DNA binding?
Damaged DNA binding (GO:0003684) is a molecular function defined as binding to damaged DNA, enabling proteins to recognize and initiate repair of DNA lesions [1,3].
What genes are involved in damaged DNA binding?
Key genes include XPA, RPA1, DDB1, DDB2, AGT, XPC, and OGG1, among others [1,3,8].
What diseases are associated with defective damaged DNA binding?
Defects cause xeroderma pigmentosum, cancer predisposition, and neurodegeneration [1,3,4].
How is damaged DNA binding measured?
Common methods include EMSA, fluorescence anisotropy, and next-generation DNA damage sequencing [4,6,8].
What is the role of DDB2 in damaged DNA binding?
DDB2 is part of the UV-DDB complex that binds UV-induced photoproducts and initiates nucleotide excision repair [1,3].
How does XPA bind to damaged DNA?
XPA binds to damaged DNA with high affinity and recruits other NER factors to the lesion site [1,8].
Can CRISPR be used to study damaged DNA binding?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect gene function in damaged DNA binding [3,5].
What is the difference between damaged DNA binding and general DNA binding?
Damaged DNA binding specifically recognizes lesions such as UV photoproducts or alkylation damage, whereas general DNA binding lacks this specificity [1,3].
What are the synonyms for damaged DNA binding?
The synonyms are DNA repair enzyme and DNA repair protein.
How does AGT recognize methyl-damaged DNA?
AGT binds to methyl-damaged DNA through a base-flipping mechanism, as revealed by biophysical studies.
Conclusion
Damaged DNA binding (GO:0003684) is a critical molecular function that initiates DNA repair and safeguards genomic integrity. The proteins involved, such as XPA, DDB2, and AGT, are essential for recognizing diverse DNA lesions and recruiting repair machinery. Defects in this function lead to xeroderma pigmentosum, cancer, and neurodegeneration, making it a prime target for therapeutic intervention. Advances in CRISPR-based models and sequencing technologies continue to unravel the mechanisms and regulation of damaged DNA binding, offering new opportunities for drug discovery and personalized medicine. EDITGENE's comprehensive services empower researchers to explore this function with precision and scale.
References
- 1. Tang J et al.. 2002. Xeroderma pigmentosum complementation group E and UV-damaged DNA-binding protein.. DNA Repair (Amst) 1(8):601-16 PMID: 12509284
- 2. Koirala RP et al.. 2024. Base flipping mechanism and binding strength of methyl-damaged DNA during the interaction with AGT.. J Biol Phys 50(1):71-87 PMID: 38150168
- 3. Stoyanova T et al.. 2009. DDB2 (damaged-DNA binding protein 2) in nucleotide excision repair and DNA damage response.. Cell Cycle 8(24):4067-71 PMID: 19923893
- 4. Mingard C et al.. 2020. Next-generation DNA damage sequencing.. Chem Soc Rev 49(20):7354-7377 PMID: 32968744
- 5. Yeh JI et al.. 2012. Damaged DNA induced UV-damaged DNA-binding protein (UV-DDB) dimerization and its roles in chromatinized DNA repair.. Proc Natl Acad Sci U S A 109(41):E2737-46 PMID: 22822215
- 6. Smider V et al.. 2006. Electrophoretic mobility shift assays to study protein binding to damaged DNA.. Methods Mol Biol 314:323-44 PMID: 16673891
- 8. Hey T et al.. 2001. Binding of XPA and RPA to damaged DNA investigated by fluorescence anisotropy.. Biochemistry 40(9):2901-10 PMID: 11258902
